We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 761-780 of 851 results
  1. Identification of a Novel Gene Encoding a PrP-Like Protein Expressed as Chimeric Transcripts Fused to PrP Exon 1/2 in Ataxic Mouse Line with a Disrupted PrP Gene

    1. Mouse lines lacking prion protein (PrP C ) have a puzzling phenotypic discrepancy. Some, but not all, developed late-onset ataxia due to Purkinje...

    Aimin Li, Suehiro Sakaguchi, ... Kazuto Shigematsu in Cellular and Molecular Neurobiology
    Article 01 October 2000
  2. Research News

    Kristine Novak in Nature Medicine
    Article 01 October 2000
  3. Alzheimer’s Disease: Physiological and Pathogenetic Role of the Amyloid Precursor Protein (APP), its Aβ-Amyloid Domain and Free Aβ-Amyloid Peptide

    To understand synaptic loss and neurodegeneration in Alzheimer’s disease, we have tried to consider the physiological functions of the amyloid...
    Conference paper 2001
  4. Aß Toxicity in Alzheimer’s Disease

    The first diagnosed Alzheimer’s disease patient was Auguste D (Fig. 1), a middle-aged woman cared for by Alsatian clinician-pathologist Alois...
    Chapter 2001
  5. Prions: from neurografts to neuroinvasion

    Spongiform encephalopathies are infectious neurodegenerative diseases caused by pathogens that seem to be devoid of any informational nucleic acids....
    M. Glatzel, M. A. Klein, ... A. Aguzzi in Prion Diseases
    Chapter 2000
  6. Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)

    It is now well established that the glial fibrillary acidic protein (GFAP) is the principal 8–9 nm intermediate filament in mature astrocytes of the...

    Lawrence F. Eng, Roopa S. Ghirnikar, Yuen L. Lee in Neurochemical Research
    Article 01 October 2000
  7. Antibodies in human infectious disease

    Investigation of human antibody responses to viral pathogens at the molecular level is revealing novel aspects of the interplay of viruses with the...

    Paul W. H. I. Parren, Pascal Poignard, ... Dennis R. Burton in Immunologic Research
    Article 01 June 2000
  8. Therapeutic control of cytokines: lessons from microorganisms

    The systems of innate and acquired immunity that protect us from the vast numbers of potential parasites that live in our environment (prions,...
    Brian Henderson in Novel Cytokine Inhibitors
    Chapter 2000
  9. Pharmacological manipulation of early PrPres accumulation in the spleen of scrapie-infected mice

    In most experimental models of scrapie and in some naturally infected species, the lymphoreticular system and the spleen in particular play a major...
    V. Beringue, F. Lamoury, ... D. Dormont in Prion Diseases
    Chapter 2000
  10. Follicular dendritic cells in scrapie pathogenesis

    Scrapie pathogenesis was studied in chimaeric mice that carried the prion protein (PrP) gene only in particular cells of the immune system. These...
    K. L. Brown, K. Stewart, ... M. E. Bruce in Prion Diseases
    Chapter 2000
  11. Cellular and sub-cellular localisation of PrP in the lymphoreticular system of mice and sheep

    Using immunocytochemistry or immunogold electron microscopy, abnormal PrP accumulation was found in lymphoreticular tissues of Suffolk sheep...
    M. Jeffrey, G. McGovern, ... K. L. Brown in Prion Diseases
    Chapter 2000
  12. Mutational Analysis of Tau in Chromosome 17-Linked Dementia

    A series of families with mixed neurodegenerative disorders has been linked to chromosome 17q21–22 by chromosome segregation analysis. Collectively,...
    K. C. Wilhelmsen, L. N. Clark, ... B. L. Miller in Fatal Attractions: Protein Aggregates in Neurodegenerative Disorders
    Conference paper 2000
  13. The prion protein globular domain and disease-related mutants studied by molecular dynamics simulations

    In humans, familial forms of transmissible spongiform enceph-alopathies (TSE; “prion diseases”) have been shown to segregate with the exchange of...
    M. Billeter, K. Wüthrich in Prion Diseases
    Chapter 2000
  14. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

    M. G. Spillantini, J.C. Van Swieten, M. Goedert in Neurogenetics
    Article 01 March 2000
  15. Polymerization of murine recombinant prion protein in nucleic acid solution

     Recombinant prion protein has been used earlier to understand the structural properties of cellular prion protein PrP C and to understand...

    P. K. Nandi, E. Leclerc in Archives of Virology
    Article 01 September 1999
  16. The Impact of Genetic Removal of GFAP and/or Vimentin on Glutamine Levels and Transport of Glucose and Ascorbate in Astrocytes

    The importance of the intermediate filament (IF) proteins glial fibrillary acidic protein (GFAP) and vimentin for astrocyte function was studied by...

    Milos Pekny, Camilla Eliasson, ... Anders Hamberger in Neurochemical Research
    Article 01 November 1999
  17. Advanced Transgenic and Gene-Targeting Approaches

    Over the past two decades the techniques associated with the manipulation of the mouse genome have provided a powerful approach toward the better...

    Xiang Gao, April Kemper, Brian Popko in Neurochemical Research
    Article 01 September 1999
  18. The neuroscience 'melting pot'

    Richard G. M. Morris in Nature Neuroscience
    Article 01 March 1999
  19. B lymphocytes in prion neuroinvasion: Central or peripheral players?

    New findings suggest that B cells are not as important for prion replication in peripheral tissues and for prion transport to the central nervous...

    John Collinge, Simon Hawke in Nature Medicine
    Article 01 December 1998
Did you find what you were looking for? Share feedback.